Denosumab for High Risk SMM and SLiM CRAB Positive, Early Myeloma Patients
Clinical trial NCT03792763 · COMPLETED
Trial details
- NCT number
- NCT03792763
- Sponsor
- Arbeitsgemeinschaft medikamentoese Tumortherapie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-30
- Primary completion
- 2023-09-14
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.